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ABSTRACT
Numerous studies have examined relationships between adrenal glucocorticoids
and the immune system’s ability to fight disease. The relationship can vary, with
glucocorticoids having either stimulatory or inhibitory effects. The pathogenic bacterium
Mycoplasma gallisepticum (MG) elicits an adaptive immune response in birds, in which
B cells produce MG-specific antibodies to fight the infection and prevent reoccurrence.
Previous research found that Eastern Bluebirds that produce the most antibodies in
response to MG infection also have the highest glucocorticoid levels. This finding led to
the current study investigating whether corticosterone, the primary glucocorticoid in
birds, stimulates production of antibodies in response to immune challenges, or if the
nature and virulence of the challenge influences corticosterone production. I compared
results from the current study wherein Eastern Bluebirds were administered
corticosterone following vaccination against MG with those of the previous study where
birds were infected with the live pathogen. In contrast to previous findings, I found no
evidence of a positive relationship between corticosterone levels and MG-antibody
production in vaccinated birds compared to controls. In addition, the strength of the
humoral immune response was not altered in birds administered corticosterone. These
findings suggest that the positive relationship between corticosterone and humoral
immunity in previous work is associated with virulence of the pathogen.
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INTRODUCTION
Vertebrates possess a conserved endocrine response to stressors involving
activation of the hypothalamic-pituitary-adrenal (HPA) axis and the production of
glucocorticoids. These steroid hormones form part of an evolved response involved in
allocating resources away from non-vital processes such as growth, reproduction, and
immunity to promote survival (Charmandari et al. 2005). The effect of the endocrine
stress response has been widely studied with respect to aspects of the immune system,
and it is clear that glucocorticoids both directly and indirectly influence the vertebrate
immune response (Maddock & Pariante 2001). These effects may be immunostimulatory
or immunosuppressive depending on the time course of the stressor (i.e., acute versus
chronic stress) and stage of immune response (i.e., innate versus adaptive). However,
little is known about how the immune system responds to elevated glucocorticoid levels
when the pathogen varies in virulence. Studies examining virulent and avirulent pathogen
challenges can help elucidate whether there is an additional layer of context dependency
associated with elevated glucocorticoids and immunocompetence.
The vertebrate immune system is a complex and organized network of cells and
molecules that defend against infection (Delves & Roitt 2000). Vertebrates respond to
immediate, non-specific threats via the chemical and cellular defenses of the innate
immune system, as well as via the highly specialized, long-term adaptive immune
system. The innate immune system consists of defense mechanisms encoded by the
germline genes of the host, including physical epithelial barriers, bioactive proteins and
molecules, and membrane-bound and cytoplasmic receptors (Chaplin 2010).
Alternatively, the adaptive immune system is generally thought of as having two
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categories of responses – humoral and cell-mediated. The delineation between humoral
and cell-mediated immunity arises from the proliferation of antigen-specific B cells and T
cells, respectively, where B cells develop and secrete antibodies to fight infection and
prevent reoccurrence while T cells stimulate B cell antibody production and kill infected
cells (Delves & Roitt 2000; Chaplin 2010).
Glucocorticoids are steroid hormones released during the stress response through
activation of the HPA axis. Corticotropin-releasing hormone (CRH) is produced by the
hypothalamus following exposure to a stressor, stimulating the secretion of
adrenocorticotropic hormone (ACTH) from the anterior pituitary, ultimately leading to
the production of glucocorticoids in the adrenal cortex. Elevated glucocorticoids can have
adverse effects on immunity (Dhabar & McEwen 1997; Sapolsky et al. 2000; Dhabar
2009; Martin 2009). For example, glucocorticoids may be immunosuppressive (Råberg et
al. 1998; Sapolsky et al 2000) or immunostimulatory, and the direction of the relationship
may be dependent on the duration of the stressor (acute versus chronic) and the type of
immune response being examined (innate versus adaptive) (Dhabar 2009; Martin 2009).
Sapolsky et al. (2000) proposed that diminished immunity during a stress
response is adaptive when it redirects resources toward activities that increase survival.
Under these conditions, associated cells and tissues can be actively catabolized when
necessary to provide proteins and carbohydrates for more demanding purposes, such as
fleeing or fighting (Martin 2009). Initially, a polyclonal immune response to antigens
occurs where multiple different B and T cells proliferate. However, glucocorticoids can
initiate clearance of low affinity B and T cell lineages (Sapolsky et al. 2000). For
example, under conditions of chronic stress where high levels of glucocorticoids are
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sustained in the blood for prolonged periods, glucocorticoids atrophy the thymus and
other lymphoid tissues, triggering apoptosis in immature B and T cells and mature T cells
(Sapolsky et al. 2000). In general, suppressive effects of glucocorticoids present in the
form of halting differentiation, maturation, and proliferation of all immune cells to
suppress primary defenses and their actions (Sapolsky et al. 2000; Sternberg 2006).
On the other hand, glucocorticoids have also been found to have stimulatory
effects on the immune system. Perhaps the strongest evidence for immunostimulatory
effects of glucocorticoids comes from observed changes in the distribution of leukocytes
following surgery, infection, vaccination, and wounding (Dhabar 2009). Leukocyte
redistribution through the blood provides an important representation of the state of
activation of the innate and adaptive immune system (Dhabar 2009), and glucocorticoids
have been identified as rapid and significant inducers of this redistribution process by
stimulating neutrophil production (Fauci & Dale 1974; Dhabar et al. 1996; Cavalcanti et
al. 2007). Glucocorticoids play an important role in promoting the maturation of
neutrophils in the bone marrow and favor the mobilization of neutrophils into the
bloodstream via a cascade of events initiated by interactions with glucocorticoid
receptors, ultimately aiding in immune surveillance capabilities (Cavalcanti et al. 2007;
Shini et al. 2010). The immune enhancing effects of glucocorticoids are generally
hypothesized to be integral to recovering from stressors and wounds that would otherwise
reduce fitness (Bonier et al. 2009; Martin 2009). Together, the immunostimulatory and
immunosuppressive effects of glucocorticoids generate bidirectional effects on immune
function.
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Whether glucocorticoids are enhancive or suppressive depends on a variety of
factors that contribute to the multifaceted nature of the relationship between the stress
and immune responses (Buchanan 2000). These factors include the duration of stress,
concentrations of glucocorticoids, and the timing of stress hormone production relative to
the timing of the immune response (Broug-Halab & Kraal 1996; Dhabar 2009). For
example, increased innate and adaptive immune activity often occurs in association with
short-term (acute) stressors, while long-term (chronic) stressors are often found to
suppress innate and adaptive immune function (Dhabar 2002; Martin 2009). Furthermore,
initial elevations in glucocorticoids have been shown to stimulate processes involved in
early inflammation, followed by elevation of T cell activity and finally B cell activity,
whereas persistent elevations by these same hormones over the course of weeks to
months suppresses all three processes (Martin 2009). In general, at the beginning of an
immune response, factors such as leukocyte trafficking, antigen presentation, helper T
cell function, and cytokine and chemokine function are enhanced by glucocorticoids,
whereas, at later stages of the stress response, these components are suppressed
(Viswanathan et al. 2005). Taken together, these findings suggest the relationship
between glucocorticoids and the immune system is dependent on the duration of the
stressor, with acute elevations in glucocorticoids exhibiting stimulatory effects and
chronic elevations exhibiting suppressive effects on innate and adaptive immune
responses (Dhabar & McEwen 1997; Dhabar 2009; Martin 2009).
Among vertebrates, corticosterone and cortisol are the main glucocorticoids
involved in the stress response. By suppressing non-vital physiological processes, and
redistributing resources to processes immediately needed for survival, glucocorticoid
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production allows animals to respond to changing energy demands (Sapolsky et al. 2000;
Angelier & Wingfield 2013). In addition to mediating energetic demands under stressful
conditions, glucocorticoids interact with cytokines, neutrophils, monocytes, natural killer
cells, T cells, and B cells of the immune system, making it an important factor for
understanding the adaptive nature of host immune responses (Dhabar 2002, 2009; Love
et al. 2016). In birds, corticosterone is a potent modulator of the innate immune response
(Butler et al. 2010; Schoech et al. 2011). For example, Merrill et al. (2014) used Redwinged Blackbirds (Agelaius phoeniceus) to examine the relationship between
corticosterone levels and bacterial killing ability (BKA) against a novel strain of Escheria
coli (Merrill et al. 2014). BKA is dependent on circulating complement and acute phase
proteins, which provide an early line of defense against invading bacterial pathogens as
part of the constitutive innate immune system (Merrill et al. 2012). The results showed a
significant positive relationship between corticosterone levels and BKA, suggesting that
elevated glucocorticoid levels enhanced innate immune ability (Merrill et al. 2014).
Conversely, House Sparrows (Passer domesticus) treated with mitotane (a
corticosterone synthesis inhibitor) followed by corticosterone injections were used to
investigate the role of corticosterone in suppressing the innate immune response (Gao &
Deviche 2019). Mitotane inhibits the production of corticosterone by suppressing P-450
cytochromes involved in steroid synthesis (Young et al. 1973). In this study all birds were
given a mitotane injection, followed by an injection of corticosterone dissolved in peanut
oil for experimental groups to restore plasma corticosterone levels, or a peanut oil vehicle
for controls. Following acquisition of blood samples to measure baseline hormone levels,
birds were placed in a breathable cloth bag for one hour to induce a stress response, and
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then a second blood sample was taken (Gao & Deviche 2019). A bacterial killing assay
against E. coli and a hemolysis-hemagglutination assay were used to measure constitutive
innate immune responses in individuals (Gao & Deviche 2019). Mitotane-treated,
vehicle-injected birds did not show any significant differences between baseline and
stress-induced bacterial killing ability or lysis scores, while mitotane-treated,
corticosterone-injected birds showed significantly lower bacterial killing ability, lysis
scores, and agglutination scores after stress trials (Gao & Deviche 2019). These results
suggest that prolonged elevation in plasma corticosterone suppresses complementmediated and bactericidal activity (Merrill et al. 2012; Gao et al. 2016).
Corticosterone has been shown to induce differing acute and chronic effects on
the adaptive immune response in a single species. For example, Martin et al. (2019)
investigated the effects of different corticosterone exposure durations on Zebra Finch
(Taeniopygia guttata) responses to West Nile Virus (WNV; Martin et al. 2019).
Corticosterone injections were used to reflect acute elevations, while silastic
corticosterone implants were used to reflect chronic elevations. Three treatment groups
were available for comparison: 1) controls (sham-implanted and vehicle-injected), 2)
corticosterone-implanted (hormone filled-silastic-implanted and vehicle-injected), and 3)
corticosterone-injected (sham-implanted and corticosterone-injected). Corticosterone
injections and implantations elevated circulating corticosterone to a similar degree,
however, the type of exposure had distinct effects on WNV responses (Martin et al.
2019). Corticosterone-implanted individuals reached higher viremia and suffered more
mortality to WNV than both control and corticosterone-injected individuals (Martin et al.
2019). Although short term enhancement of the immune response was not observed,
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chronic corticosterone elevation caused significant immune suppression consistent with
previous findings (Dhabar 2009; Martin 2009).
The dynamics of the corticosterone-immune response relationship remain unclear,
and further experimental testing is necessary to determine if the relationship changes with
respect to the type and severity of the immune challenge. For instance, Shini et al. (2008)
conducted a study on chickens (Gallus gallus domesticus) to address whether the
relationship between adaptive immunity and a non-infectious stress response differs from
the response towards bacterial stressors (Shini et al. 2008). In this study, one group of
birds was supplemented with corticosterone dissolved in ethanol and diluted in drinking
water to mimic a stress response, and were challenged with an infectious bronchitis virus
(IBV), while a separate group was injected with lipopolysaccharide (LPS) from
Escherichia coli and challenged with the same IBV vaccine (Shini et al. 2008). Both of
these groups were compared to controls that received the IBV vaccine but were otherwise
untreated. Compared to controls, birds supplemented with corticosterone showed a
significant acute increase in IBV-specific antibody titers, followed by a significant
decrease in these titers under chronically elevated corticosterone levels, whereas the LPS
treatment group showed a significant initial reduction in IBV antibody titers, but returned
to basal levels by the end of the 10-day experiment (Shini et al. 2008). These results
indicate that the stress response differentially affects the immune response depending on
the demands of the challenge. Specifically, the findings in Shini et al. (2008) suggest that
corticosterone interacts with a non-pathogenic and/or avirulent challenge differently than
it does when the challenge is due to a live, virulent pathogen.
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Additionally, presentation of a viral challenge to barn owl (Tyto alba) nestlings
affects the nature of the relationship between corticosterone and the adaptive immune
response (Stier et al. 2009). Nestlings were divided into four groups, where a control
group received a phosphate-buffered saline (PBS) solution and a slow-releasing placebo
implant. Three experimental groups received a PBS solution and a corticosterone
implant, a Tetravac vaccine and a placebo implant, or a Tetravac vaccine and a
corticosterone implant, respectively (Stier et al. 2009). The Tetravac vaccine consisted of
a mixture of antigens (diphtheria, tetanus, pertussis, filamentous hemagglutinin, and type
1, 2, and 3 poliovirus D antigens), which was injected subcutaneously in the neck (Stier
et al. 2009). PBS-injected groups did not differ in their production of IgY antibody titers
despite corticosterone supplementation under chronic conditions, however, Tetravacinjected groups did differ in their IgY antibody production as chronically elevated
corticosterone caused a significant decrease in antibody production over the course of 1217 days (Stier et al. 2009). These results suggest that the nature of the relationship
between corticosterone and humoral immunity is affected by the presentation of an
antigenic challenge, such that chronically elevated corticosterone differentially
suppresses the adaptive immune system as a way of avoiding harmful secondary effects
of mounting an immune response, such as oxidative stress and immunopathology (Råberg
et al. 1998; Dhabar 2009; Stier et al. 2009).
The current study focuses on the chronic phase immune response of a novel hostpathogen system, utilizing non-pathogenic and pathogenic challenges from which I
sought to determine the nature of the relationship between corticosterone and the humoral
immune system. This was done by using killed and live forms of the naturally occurring
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avian pathogen, Mycoplasma gallisepticum (MG). MG is an avian bacterial pathogen that
causes respiratory infection and conjunctivitis in many bird species (Levisohn & Kleven
2000). Initially causing infection in poultry, MG has since become endemic among many
species of passerines in the Eastern U.S., including the Eastern Bluebird (Sialia sialis;
Dhondt et al. 2008; Balenger 2019; Sawicka et al. 2020). A recent experimental infection
of Eastern Bluebirds with a live, virulent MG strain suggests that MG localizes in the
choanal cleft palate of these birds, and that infection leads to costs associated with a
reduction in fitness (Balenger 2019). Experimental infection with MG elicits a strong
humoral immune response, in which the host’s immune system produces MG-specific
antibodies within 13 days of infection. Interestingly, there was a significant positive
correlation between plasma corticosterone levels and MG-specific antibody levels in this
study, but whether the relationship is causally related to corticosterone levels is unclear
(Balenger, unpubl. data).
This study was aimed at elucidating the relationship between chronic stress and
immunity. To do so, I examined the relationship between humoral antibody production
and corticosterone levels from a correlative and causal perspective in Eastern Bluebirds.
Using a bacterin, or suspension of killed MG bacteria, as an experimental immune
challenge, I first asked whether the level of antibodies produced 13 days after vaccination
is associated with the concentration of corticosterone in circulation. A positive
relationship between antibody production and corticosterone levels would support the
hypothesis that corticosterone promotes antibody production, while a negative response
would support the hypothesis that corticosterone suppresses the humoral immune
response.
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To more directly address the potential for a causal relationship between the
concentration of corticosterone and strength of a humoral immune response to
vaccination with the MG bacterin, I chronically elevated corticosterone levels in a subset
of control and vaccinated birds. If corticosterone-treated birds respond to vaccination
with greater antibody production than non-corticosterone-treated birds, this would
support a causal relationship between corticosterone and humoral immunity, such that
increasing corticosterone stimulates antibody production. Alternatively, if corticosteronetreated birds respond to vaccination with lower antibody production than noncorticosterone-treated birds, this would support a causal relationship between
corticosterone and humoral immunity, such that increasing corticosterone suppresses
antibody production. If the corticosterone manipulation does not alter the mean
production of antibodies, such results would suggest that corticosterone does not directly
affect the production of antibodies during a bacterin challenge.
Finally, I incorporate data from a previous study (Balenger, unpubl. data) to
examine whether the relationship between the strength of the humoral immune response
and corticosterone production is context dependent. Specifically, I ask whether the nature
and virulence of the challenge will influence the relationship between corticosterone
production and humoral immunity. A positive relationship between corticosterone levels
and antibody levels would support the hypothesis that corticosterone is stimulating the
humoral immune system regardless of the type of challenge. Alternatively, if antibody
production and corticosterone are negatively related in response to vaccination, this
would support the hypothesis that immune allocation is dependent on the virulence of a
pathogen.
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MATERIALS AND METHODS
Field Work and Captivity
Populations of box-nesting Eastern Bluebirds were monitored from March-August
2019 at the University of Mississippi Golf Course (Oxford, MS, USA) and the University
of Mississippi Field Station (Abbeville, MS, USA) to establish hatching date. Eastern
Bluebirds typically produce 4-5 nestlings per breeding attempt. When nestlings were 1517 days old, each nestling in a brood was weighed to the nearest ± 0.01g and the heaviest
of these was collected and brought to the aviary facility at the University of Mississippi
Field Station. In total, 19 Eastern Bluebird fledglings were placed in individual wire bar
cages, each measuring 51 cm high x 51 cm wide x 102 cm long. Cages were arranged in
stacks of three, and each bird was provided with four wooden perches along with food
and water cups. Mealworms (Tenebrio molitor) and waxworms (Galleria mellonella)
(Rainbow Mealworms, CA, USA) were provided ad libitum, and water was provided
with one daily drop of a soluble vitamin supplement (Wild Harvest Premium Multi-Drop
for birds). The temperature of the animal care room remained at 28-30℃, and a 12:12
light:dark cycle was utilized throughout the experiment. Captivity lasted 25-70 days
before beginning the experiment to allow for acclimation. All animal protocols and
procedures were conducted according to the University of Mississippi Institutional
Animal Care and Use Committee (IACUC) approved protocol (#19-019).
Experimental Procedures
Vaccine challenge
Birds were haphazardly divided into four groups based upon a two-by-two
experimental design of corticosterone supplementation vs. MG vaccination. A control
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group was injected with a mineral oil emulsion and given a daily supplement of two
waxworms previously injected with peanut oil (n = 5). The three experimental groups
consisted of a group injected with a killed vaccine suspended in a mineral oil emulsion
and supplemented daily with two waxworms injected with peanut oil (n = 5), a group
injected with a mineral oil emulsion and supplemented daily with two waxworms injected
with corticosterone (n = 5), and a group injected with a killed vaccine suspended in a
mineral oil emulsion and supplemented daily with two waxworms injected with
corticosterone (n = 4), respectively.
The vaccine contained an inactivated, oil-emulsion MG bacterin (MG-Bac; Zoetic
Animal Health; MI, USA) and was administered using a 3/10cc U-100 insulin syringe
(UltiCare VetRx; MN, USA). 50 µL of the vaccine was injected subcutaneously at the
base of the neck once on day 0 representing the beginning of the experiment in August
2019. Birds that did not receive the vaccine were injected with 50 µL of the mineral oil
emulsion only. Corticosterone was administered by injecting waxworms with 50 µL of
corticosterone suspended in peanut oil using a 3/10cc U-100 insulin syringe following the
methods of Breuner et al. (1998). We used a 1.0 mg/mL concentration of corticosterone,
thus, birds received 50 µg corticosterone per waxworm. Birds were fed two waxworms
each at seven o’clock a.m. daily over the course of the 13-day experiment for a total
dosage of 100 µg corticosterone per day. Birds that did not receive corticosterone were
fed two waxworms each containing 50 µL of a peanut oil vehicle only. On days 0, 2, 6,
and 13, birds were hand-fed and subsequently placed in a brown paper bag for five
minutes prior to blood sampling (Breuner et al. 1998).
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Approximately 100 µL of whole blood was collected from the brachial vein of
each bird using heparinized microhematocrit capillary tubes. Within 20 minutes of
collection, whole blood samples were centrifuged, and the serum component was
separated from the red blood cells. Serum was then divided between two 1.5 mL flip-cap
microcentrifuge tubes per bird for each day of blood collection: one tube for antibody
evaluation, and one tube for corticosterone evaluation. These samples were placed in a
freezer at -20 ℃ at the University of Mississippi Field Station animal care building until
they could be transferred to the lab freezer at the University of Mississippi (University,
MS, USA). Birds were weighed to the nearest ± 0.01 g prior to supplementation at each
of these timepoints. Tarsus length was measured to the nearest ± 0.1 mm on day 13.
Pathogen challenge
Detailed methods regarding the live MG experimental infection are provided in
Fry (2019). Here I provide a brief summary of the relevant aspects for evaluation of the
current study. In 2017, wild-caught adult Eastern Bluebirds were similarly housed in
individual wire bar cages, each measuring 51 cm high x 51 cm wide x 102 cm long.
Cages were arranged in stacks of three and birds were housed in a Biosafety Level 2
animal care room in the Department of Biology, University of Mississippi (Shoemaker
Hall). Each bird was provided with wooden perches; water and mealworms (Fluker
Farms, LA, USA) were provided ad libitum. Birds were kept under a 12:12 light:dark
cycle at a temperature of 21-23°C. In all, 23 birds were quarantined, which lasted
between 30-97 days. No birds showed clinical symptoms of infection during this time
period. All procedures for maintenance and care of the birds were conducted according to
Institutional Animal Care and Use Committee (IACUC) approved protocols (#17-012).
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Procedure for euthanizing birds was carried out according to IACUC approved Standard
Operating Procedures (#17-013).
Twenty-four hours prior to the start of the experiment, a blood sample was
collected from each bird to verify the absence of MG antibodies and quantify preinfection circulating levels of corticosterone. Serum antibodies and corticosterone were
evaluated using a commercial ELISAs (antibodies: Affinitech, AR, USA; corticosterone:
Cayman Chemical, MI, USA). Birds were also weighed to the nearest ± 0.01 g and tarsus
length was obtained with digital calipers to the nearest ± 0.1 mm.
Birds were haphazardly assigned to control and treatment groups, (n = 12 control
birds; n = 11 infected birds). Following standard protocols (Farmer et al. 2005), control
birds were ocularly inoculated with sterile SP4 media, and infected birds were similarly
inoculated with a cultured MG field isolate collected from a wild House Finch in January
2007 (Bonneaud et al. 2011; Balenger et al. 2015). Briefly, birds were treated by bilateral
ocular inoculation of either sterile SP4 media (control birds) or 1 x 104 to 1 x 106 color
changing units of MG culture (infected birds) added dropwise to both eyes of each bird.
All birds were maintained in the same room, but control and infected birds were
separated from one another by ZipWall barrier panels. Birds were visually monitored
every day for symptoms of conjunctivitis. Blood samples were collected within 3 min of
handling each bird on days 2, 6, and 13 following infection. Within 20 minutes of
collection, whole blood samples were centrifuged, and the serum component was
separated from the red blood cells. Serum was stored at -20°C until assays were
performed. Body mass was also collected at each of these timepoints.
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MG-Antibody Detection
The relative concentration of MG-specific antibodies was determined for serum
samples collected on day 0 and day 13 using a commercially available enzyme-linked
immunosorbent assay (ELISA; IDEXX, ME, USA). This assay comes coated with an
MG antigen attached to the bottom of each well, utilizing an indirect ELISA format. If
antibodies from the sample serum are present, they will bind to the pre-coated antigens
and will subsequently be bound by an enzyme-labeled, anti-species globulin conjugate.
An enzyme substrate-chromogen reagent is then added to each well which causes a blue
color to develop in the wells where antibody is present. This color is directly proportional
to the amount of bound sample antibody, meaning a darker color represents a greater
number of antibodies present in the sample serum. Each sample was run in duplicate. We
measured absorbance values of each well using a BioTek plate reader set to read at a
wavelength of 630 nm. This assay allowed both for binary assignment to negative and
positive groups (cutoff between negative and positive for arbitrary ELISA units = 0.009;
Hawley et al. 2011; Amonett 2020) as well as relative determination of strength of
antibody response.
Corticosterone Detection
The concentrations of corticosterone on day 0 and those accumulated by day 13
were measured using a commercially available corticosterone ELISA kit (Cayman
Chemical, MI, USA). This assay is based on competition between sample corticosterone
and a corticosterone-acetylcholinesterase (AChE) conjugate for a limited amount of
corticosterone antiserum. The amount of sample corticosterone varies while the
concentration of the corticosterone tracer remains constant, therefore, the amount of
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tracer able to bind to the antiserum is inversely proportional to the concentration of free
corticosterone in the well. The antiserum-corticosterone complex binds to the mouse antirabbit IgG, and then Ellman’s Reagent is added to the well. Ellman’s Reagent contains
the substrate to acetylcholinesterase (i.e. acetylthiocholine) as well as 5,5’-dithio-bis-(2Nitrobenzoic Acid). AChE hydrolyzes acetylthiocholine into thiocholine, which then
undergoes a non-enzymatic reaction with 5,5’-dithio-bis-(2-Nitrobenzoic Acid) to
produce 5-thio-2-nitrobenzoic acid, which has a distinct yellow color. The intensity of
this color is proportional to the amount of corticosterone tracer bound to the well, which
is inversely related to the amount of free corticosterone in the sample. After developing
the corticosterone ELISA, we measured absorbance values of each well in a BioTek plate
reader at a wavelength of 405 nm. Each sample was run in triplicate. The concentration
of corticosterone in plasma samples was calculated by using a standard curve determined
by standard samples run in duplicate on each plate.
Data Analysis
All analyses were performed using SAS v. 9.4. Residuals from regressing mass
against tarsus length were calculated and used as a proxy for body condition. To first
verify treatment effects, Wilcoxon rank sums with exact p-values were used to evaluate
whether 1) corticosterone supplementation increased the concentration of circulating
corticosterone, and 2) vaccination increased MG antibody titers. To more generally
assess whether treatments influenced appetite or overall health, we used Wilcoxon rank
sums with exact p-values to whether corticosterone supplementation or vaccination
affected body condition. We used Spearman correlations to evaluate whether antibody
levels of 1) vaccinated and 2) infected birds were associated with concentration of
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endogenous circulating corticosterone for birds not given supplemental corticosterone.
We used a Fisher’s exact test to examine whether corticosterone supplemented birds
differed from non-supplemented birds in their likelihood to seroconvert. Furthermore, we
evaluated whether corticosterone supplementation affects the mean antibody titer
production of vaccinated birds relative to birds that were not vaccinated using Wilcoxon
rank sums with exact p-values.
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RESULTS
Treatment validation
Corticosterone levels did not differ between control and corticosterone
supplementation groups prior to supplementation (Figure 1; p = 0.41). Corticosterone
levels, however, were significantly higher in supplemented birds than non-supplemented
birds 13 days later (Figure 1; p = 0.03). Tukey post-hoc tests revealed that corticosterone
levels of non-supplemented control and vaccinated birds did not significantly differ from
one another, but both groups were significantly different from corticosterone
supplemented and vaccinated birds. Birds receiving a corticosterone supplement but no
vaccine did not significantly differ from any other group (Figure 1). Body condition did
not significantly differ between control and corticosterone supplemented groups prior to
supplementation or 13 days later (day 0: p = 0.82; day 13: p = 0.76).
All 19 birds tested negative for circulating MG antibodies prior to vaccination (all
EU < 0.002). Antibody levels reached the positive cutoff value for 0/10 unvaccinated
birds and 2/9 vaccinated birds by day 13. Antibody levels overall were not greater in
vaccinated birds than unvaccinated birds (Figure 2; p = 0.12). Tukey post-hoc tests
identified no significant differences in MG antibody titers across the four treatment
combinations (Figure 2). Body condition did not differ between control and vaccinated
groups prior to inoculation or 13 days later (day 0: p = 0.08; day 13: p = 0.57).
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Figure 1. Effects of corticosterone supplementation and MG bacterin
vaccination (x-axis) on plasma corticosterone levels (y-axis, higher
concentration upwards) across the four treatment groups. Shown are means
+/- standard error on day 13. “A” and “B” symbols represent significant
differences from each other (p = 0.03), while “AB” symbol represents no
differences from any other group.
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Figure 2. Effects of corticosterone supplementation and MG bacterin
vaccination (x-axis) on MG antibody production (y-axis, higher production
upwards) across the four treatment groups. Shown are means +/- standard
error on day 13. “A” symbols above columns represent non-significant
differences across the four treatment groups (p = 0.12).
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Response to vaccine and pathogen challenges – no corticosterone supplementation
Among non-corticosterone supplemented birds, antibody levels surpassed the
positive cutoff value for seroconversion in 2/5 vaccinated and 5/9 infected birds by day
13. There was a significant positive relationship between MG antibody titers and
corticosterone among birds infected with live MG (Figure 3, top; rho = 0.72, p = 0.03).
Among vaccinated birds, the relationship between MG antibody titers and corticosterone
was not significant (Figure 3, bottom; rho = 0.56, p = 0.32). Antibody titers and
corticosterone were not significantly correlated between control birds in either study (MG
infection control: rho = -0.20, p = 0.52; vaccination control: rho = -067, p = 0.22).
Effect of corticosterone supplementation on humoral response to vaccination
Among vaccinated birds, corticosterone supplementation did not significantly
affect whether a bird seroconverted (p = 0.44). Furthermore, corticosterone
supplementation did not significantly affect relative MG titers (Figure 4; p = 0.76), such
that corticosterone supplemented birds had neither increased nor decreased MG
antibodies in their circulation relative to non-corticosterone supplemented birds.
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Figure 3. Top) Significant positive correlation between corticosterone levels (x-axis,
higher concentration to the right) and MG antibody count (y-axis, higher production
upwards) showing the atypical relationship between stress-level and humoral immune
response in Eastern Bluebirds (p = 0.03). Red circles represent birds inoculated with a
live MG bacteria strain, while blue circles represent birds inoculated with sterile SP4
media (Balenger, unpubl. data). Bottom) Non-significant correlation between intrinsic
corticosterone levels and MG antibody count between Eastern Bluebirds vaccinated with
a killed MG bacterin strain (red circles) and those injected with a mineral oil emulsion.
(blue circles).
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Figure 4. Non-significant correlation between corticosterone levels and MG antibody
count between Eastern Bluebirds vaccinated with a killed MG bacterin strain and not
supplemented with corticosterone (red circles) and those vaccinated with a killed MG
bacterin strain and supplemented with corticosterone (blue circles).
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DISCUSSION
In this study we experimentally elevated the circulating corticosterone levels in
Eastern Bluebirds challenged with an MG vaccine to determine 1) if chronically elevated
corticosterone level is causally associated with the humoral immune response, and 2) if
the relationship between corticosterone level and adaptive humoral immunity is
dependent upon contextual differences in the form of a pathogenic and a non-pathogenic
immune challenge. We found that corticosterone administration was effective at
increasing circulating corticosterone levels within the upper physiological range,
however, we did not detect a significant relationship between corticosterone levels and
the humoral immune response to a vaccine challenge. When challenged with a live,
virulent pathogen (MG), however, birds with the highest corticosterone levels also had
the highest antibody titers (Balenger, unpubl. data), supporting the interpretation that the
relationship between corticosterone levels and the strength of the humoral immune
response is dependent upon the type of health risk imposed by the immune challenge.
The data are conflicting and, based upon what we know about chronic stress and
immunosuppression, the latter results are likely to be spurious. Unfortunately, small
sample sizes and a low seroconversion rate mean that this study would likely only be able
to identify very strong relationships, thus a larger study is warranted to more definitely
reject our hypotheses.
Administration of corticosterone-filled waxworms effectively increased plasma
corticosterone titers within the upper physiological range of natural variation in baseline
corticosterone of birds (0.7 – 57 ng/mL) (Hau et al. 2010). This method of corticosterone
supplementation may be more effective at inducing chronic-state conditions than the
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common approach of implanting silastic pellets filled with corticosterone. Such
implanted ‘slow-release’ pellets have been shown to induce an initial peak in hormone
levels followed by rapid hormone depletion over longer chronic stages (Quispe et al.
2015; Vágási et al. 2018). In contrast, repeated application of acute stressors has been
shown to elicit physiological and behavioral changes consistent with chronic stress in
many species (Cyr et al. 2007; Rich & Romero 2005).
This study presents preliminary data that does not support our alternative
hypotheses that chronic corticosterone administration will either suppress or stimulate the
adaptive immune system during a vaccine challenge, as we found no differences across
corticosterone-treated groups in the amount of MG-specific antibody production. In
contrast to previous studies where chronic corticosterone administration was shown to
suppress adaptive immunity (Martin et al. 2019; Stier 2009), these results suggest that
corticosterone may not directly affect the quantity of antibodies produced in response to a
bacterin challenge. It is possible that corticosterone exhibits indirect effects on the
adaptive immune system by working in conjunction with other stress-mediated
hormones, including testosterone and catecholamines, or by regulating the amount and
type of glucocorticoid receptors present on immune cells (Roberts et al. 2007; Dhabar
2009).
The atypical relationship between corticosterone and the MG-specific adaptive
immune response observed in the previous infection study (Balenger, unpubl. data)
served as a catalyst for the current study to better understand the interactions between
corticosterone and the chronic phase response of the adaptive immune system, as well as
the nature of the relationship between glucocorticoids and humoral immune function in
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different contexts. Two interpretations could be drawn from the infection study: 1)
Eastern Bluebirds are not typically bound by the negative relationship between antibody
production and chronically elevated corticosterone levels, or 2) the costs of
immunosuppression are presumably greater than the potential benefits when dealing with
a live, disease-causing pathogen. Due to the small sample size, the current vaccination
study does not allow us to definitely refute or accept either of these hypotheses; however,
the fact that we found a significant positive relationship between corticosterone level and
antibody level in response to infection, but did not find such a relationship in response to
vaccination does lend some support to the hypothesis suggesting greater costs of
immunosuppression during a live infection. Future work will increase sample sizes to
tease apart the apparent pathogen-dependent effects between corticosterone and the
humoral immune response.
Our study contributes to the growing knowledge of the effects of glucocorticoids
on the innate and adaptive immune systems. It is important to recognize that this study
solely focused on the relationship between corticosterone and one measure of the
adaptive humoral component of the vertebrate immune system. In reality, corticosterone
has been shown to have contrasting stimulating and suppressing effects on multiple
immune parameters, including innate complement, cytokine, natural killer cell, and
macrophage activity, as well as acquired cell-mediated T cell functions and humoral
antibody production (Sapolsky et al. 2000; Dhabar 2002, 2009; Merrill et al. 2012, 2014;
Gao & Deviche 2019). Therefore, future studies examining both innate and adaptive
components of the vertebrate immune system over acute and chronic stages of the
endocrine response would allow for better understanding of the effects that corticosterone
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has on the immune system (Dhabar 2009; Martin 2009). Additionally, other factors such
as sex, age, and species-specificity should be considered when interpreting relationships
between stress and immune responses as the relationship may differ depending on the
perception of threat and the molecular machinery employed by each individual host when
facing a stressor or an immune challenge (Martin et al. 2005; Merrill et al. 2012; Love et
al. 2016).
In conclusion, the relationship between stress and the immune system remains
complex and widely contested with different studies showing contrasting effects of
glucocorticoids on both innate and adaptive immune responses (Dhabar & McEwen
1997; Sapolsky et al. 2000; Shini et al. 2008; Merrill et al. 2012, 2014; Gao & Deviche
2019; Martin et al. 2019). Our study advocates for a more thorough investigation into
additional layers of context-dependency that may be driving the relationship between
glucocorticoids and investment in immunity, such as the virulence of a pathogenic
challenge. Ultimately, these investigations could provide insight into our understanding
of the plasticity of the immune response as hosts are expected to optimally respond to
innumerable challenges along a continuous spectrum of risk to their health and survival.
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